Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AIM ImmunoTech Q3 EPS $(1.57) Misses $(0.98) Estimate, Sales $26.000K Down From $35.000K YoY

Author: Benzinga Newsdesk | November 18, 2025 08:57am
AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(1.57) per share which missed the analyst consensus estimate of $(0.98) by 59.39 percent. This is a 73.83 percent increase over losses of $(6.00) per share from the same period last year. The company reported $26.000 thousand in sales this quarter. This is a 25.71 percent decrease over sales of $35.000 thousand the same period last year.

Posted In: AIM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist